Respiri Extends US partnership with Access Telehealth
Respiri (RSH) signs a second, five-year, non-exclusive distribution and marketing agreement with Access Telehealth in the United...
Respiri (RSH) has received United States Food and Drug Administration (FDA) clearance for its wheezing aid, Wheezo
Wheezo monitors wheezing to manage and...
